Emily Puumala
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Characterizing antimicrobial activity of environmental Streptomyces spp. and oral bacterial and fungal isolates from Canis familiaris and Felis catus.
Journal: mSphere
Published: April 14, 2025
Chemoproteomic Profiling of C. albicans for Characterization of Antifungal Kinase Inhibitors.
Journal: Journal of medicinal chemistry
Published: March 20, 2025
Structure-guided optimization of small molecules targeting the yeast casein kinase, Yck2, as a therapeutic strategy to combat Candida albicans.
Journal: Research square
Published: January 27, 2025
Butyrolactol A potentiates caspofungin efficacy against resistant fungi via phospholipid flippase inhibition.
Journal: bioRxiv : the preprint server for biology
Published: January 20, 2025
Chemoproteomic Profiling of C. albicans for Characterization of Anti-fungal Kinase Inhibitors.
Journal: bioRxiv : the preprint server for biology
Published: January 20, 2025
Butyrolactol A enhances caspofungin efficacy via flippase inhibition in drug-resistant fungi.
Journal: Cell
Published: December 12, 2024
Structure-guided optimization of small molecules targeting Yck2 as a strategy to combat Candida albicans.
Journal: Nature communications
Published: December 03, 2024
Naamidine A reveals a promising zinc-binding strategy for topical antifungal therapy.
Journal: Antimicrobial agents and chemotherapy
Published: September 26, 2024
Advancements and challenges in antifungal therapeutic development.
Journal: Clinical microbiology reviews
Published: January 31, 2024
Cyprocide selectively kills nematodes via cytochrome P450 bioactivation.
Journal: Nature communications
Published: October 25, 2023
Allosteric inhibition of tRNA synthetase Gln4 by N-pyrimidinyl-β-thiophenylacrylamides exerts highly selective antifungal activity.
Journal: Cell chemical biology
Published: October 16, 2023
Last Updated: 09/26/2026